Aligos Therapeutics (ALGS) Asset Utilization Ratio (2021 - 2025)
Historic Asset Utilization Ratio for Aligos Therapeutics (ALGS) over the last 5 years, with Q3 2025 value amounting to 0.02.
- Aligos Therapeutics' Asset Utilization Ratio fell 5779.37% to 0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02, marking a year-over-year decrease of 5779.37%. This contributed to the annual value of 0.03 for FY2024, which is 4796.45% down from last year.
- Per Aligos Therapeutics' latest filing, its Asset Utilization Ratio stood at 0.02 for Q3 2025, which was down 5779.37% from 0.02 recorded in Q2 2025.
- In the past 5 years, Aligos Therapeutics' Asset Utilization Ratio registered a high of 0.13 during Q3 2023, and its lowest value of 0.02 during Q4 2021.
- Moreover, its 5-year median value for Asset Utilization Ratio was 0.05 (2024), whereas its average is 0.06.
- Per our database at Business Quant, Aligos Therapeutics' Asset Utilization Ratio skyrocketed by 41171.59% in 2022 and then tumbled by 6116.8% in 2024.
- Over the past 5 years, Aligos Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.02 in 2021, then surged by 411.72% to 0.09 in 2022, then increased by 3.93% to 0.09 in 2023, then tumbled by 51.02% to 0.05 in 2024, then crashed by 52.9% to 0.02 in 2025.
- Its last three reported values are 0.02 in Q3 2025, 0.02 for Q2 2025, and 0.03 during Q1 2025.